Table 1. Discovery Cohort Characteristics.
| Characteristic | Treatment Groupa | |
|---|---|---|
| CSF Diversion (n = 25) |
No CSF Diversion (n = 25) |
|
| Female, No. (%) | 15 (60) | 11 (44) |
| Gestational age, mean (SD), wk | 26 (6) | 26 (5) |
| Lateral ventricle symmetry, No. (%) | 17 (68) | 19 (76) |
| Genetic syndrome, No. (%) | 4 (16) | 4 (16) |
| Germinal matrix hemorrhage, No. (%)b | 5 (20) | 11 (44) |
| Cyst, No. (%) | 1 (4) | 0 |
| Infection, No. (%) | 0 | 1 (4) |
| Follow-up time, median (IQR), mo | NA | 29 (9-46) |
| Time to shunt placement, median (IQR), d | 6 (2-51) | NA |
Abbreviations: CSF, cerebrospinal fluid; IQR, interquartile range; NA, not applicable.
a
Unless otherwise indicated, differences between groups did not reach statistical significance (P > .10 using χ2 test or Fisher exact test in instances with <5 participants).
b
P = .08.